A Study of AG-80308 in Dry Eye Patients

Clinical trial NCT05372107 · COMPLETED

Trial details

NCT number: NCT05372107
Sponsor: Allgenesis Biotherapeutics Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Dry Eye Disease

Start date: 2022-06-13
Primary completion: 2022-11-02
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.